Received 22 April 2013
aDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Turkey,bChemistry and Environmental Division, Manchester Metropolitan University, Manchester M1 5GD, England,cChemistry Department, Faculty of Sccience, Mini University, 61519 El-Minia, Egypt,dDepartment of Chemistry, University of Leicester, Leicester, England, and ePharmaceutical Chemistry Department, Faculty of Pharmacy, Al Azhar University, Egypt
Correspondence e-mail: email@example.com
The title compound, C26H24Cl2N2, crystallizes with two independent molecules (1 and 2) in the asymmetric unit. In molecule 1, the two phenyl and 2,6-dichlorophenyl rings are inclined to the imidazole ring at angles of 74.12 (14), 26.13 (14) and 67.30 (14)°, respectively. In molecule 2, due to the different molecular environment in the crystal, the corresponding angles are different, viz. 71.72 (15), 16.14 (15) and 80.41 (15)°, respectively. In the crystal, molecules 1 and 2 are linked by C-HCl interactions, and inversion-related 2 molecules are linked by C-H interactions. There are no other significant intermolecular interactions present.
For some biological applications of imidazoles, see: Prabhu & Radha (2012); Sharma et al. (2009, 2010); Pandey et al. (2009); Sisko & Mellinger (2002); Puratchikody & Doble (2007). For the synthesis of imidazole-containing compounds and a similar structure, see: Simpson et al. (2013).
Data collection: SMART (Bruker, 2011); cell refinement: SAINT (Bruker, 2011); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2592 ).
The authors are grateful to Manchester Metropolitan University, the University of Leicester and Erciyes University for supporting this study.
Bruker (2011). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
Pandey, J., Tiwari, V. K., Verma, S. S., Chaturvedi, V., Bhatnagar, S. & Sinha, S. (2009). Eur. J. Med. Chem. 44, 3350-3355.
Prabhu, M. & Radha, R. (2012). Asian J. Pharm. Clin. Res. 5, 154-159.
Puratchikody, A. & Doble, M. (2007). Bioorg. Med. Chem. 15, 1083-1090.
Sharma, G. K., Kumar, S. & Pathak, D. (2010). Pharma Lett. 2, 223-230.
Sharma, D., Narasimhan, B., Kumar, P., Judge, V., Narang, R., De Clercq, E. & Balzarini, J. (2009). Eur. J. Med. Chem. 44, 2347-2353.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Simpson, J., Mohamed, S. K., Marzouk, A. A., Talybov, A. H. & Abdelhamid, A. A. (2013). Acta Cryst. E69, o5-o6.
Sisko, J. & Mellinger, M. (2002). Pure Appl. Chem. 74, 1349-1357.
Spek, A. L. (2009). Acta Cryst. D65, 148-155.